At close: December 20 at 8:13:48 AM GMT+1
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| DB0.MU | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | BMO Capital: Outperform to Outperform | 12/12/2024 |
| Downgrade | Guggenheim: Buy to Neutral | 12/12/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 12/11/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 12/11/2024 |
| Downgrade | Wells Fargo: Overweight to Equal-Weight | 12/11/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 12/11/2024 |
Related Tickers
9U90.MU Unity Biotechnology Inc
0.9800
-2.97%
PRNAF Alterity Therapeutics Limited
0.0036
0.00%
6JH.MU IN8bio, Inc.
0.2360
-10.61%
6JH.F IN8bio, Inc.
0.2280
-10.94%
LVCLF Algorae Pharmaceuticals Limited
0.0051
0.00%
PX91.MU Cassava Sciences Inc
2.2475
+1.95%
OCEAW Ocean Biomedical, Inc.
0.0354
-9.23%
HMTXF Hemostemix Inc.
0.0468
0.00%
CEROW CERo Therapeutics Holdings, Inc.
0.0090
-14.29%
PYPD PolyPid Ltd.
3.2200
-6.94%